Snoasis Medicalgoldencohas Pioneered The Development And Use Of Placental Tissue Products For Tissue Repair And Regeneration In Dental Oral Maxillofacial Surgeryrobert Tofesnoasis Medical S President And Founderbegan Researching The Concept Of Placental Tissue In 2006 And Founded The Company The Following Yearin 2008Snoasis Medical Partnered With A Placental Tissue Processor Currently Known As Mimedx Groupmariettaga Todaymimedx Is The Premier Global Manufacturer Of Placental Tissue Products And Is Listed On The Nasdaq Stock Exchangemdgx Snoasis Medical Owns The World Wide Distribution Rights To Current And Future Mimedx Placental Tissue Products And The Exclusive License For The Intellectual Property In The Dental Oral Maxillofacial Fields Of Usein 2014Snoasis Medical Expanded Its Regenerative Products Portfolio When It Started Marketing Maxxeusa An Extensive Line Of Allograft Bone Productsprocessed By Community Tissue Servicesdaytonoh Todaysnoasis Medical Aims To Become The Number One Dental Oral Maxillofacial Regenerative Products Company In The United States And To Share The Benefits Of Its Placental Tissue Products With The Rest Of The Worldsnoasis Medical S Lead Productbioxcludeadeepithelialized Amnion Chorion Allograftprocessed Using Puriona Delivers Multiple Extra Cellular Matrix Proteinsgrowth Factorsand Cytokines To Provide A Barrier Membrane That Enhances Healingsnoasis Medical Has Distributed Over 150 000 Grafts Since Launching Bioxclude In 2010The Fda Allows This Minimally Manipulated Tissue To Be Used As A Barrierconduitconnectoror Cushion In A Variety Of Dentalendodonticoral Maxillofacialand Periodontal Regenerative Procedurescore Valuesohonesty Ohard Workohaving Fun2X Osharing Successocontinual Learningobeing A Great Partnerolove Good Science And Research
